ADPT - Company ID 0001478320
The table below shows Adaptive Biotechnologies Corp's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $77.58M | $55.03M | $43.16M | $50.65M | $38.08M | $59.82M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $48.31M | $44.82M | $44.28M | $43.58M | $40.81M | $35.61M |
| Inventory | $11.21M | $9.93M | $8.40M | $8.68M | $11.96M | $13.21M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $291.81M |
| $281.44M |
| $261.86M |
| $256.49M |
| $308.35M |
| $351.55M |
| Property, plant & equipment | $30.77M | $37.50M | $41.05M | $44.43M | $51.31M | $55.42M |
| Goodwill | $118.97M | $118.97M | $118.97M | $118.97M | $118.97M | $118.97M |
| Total assets | $505.94M | $490.61M | $496.64M | $510.85M | $558.51M | $584.87M |
| Accounts payable | $9.62M | $10.27M | $6.91M | $6.36M | $7.35M | $9.87M |
| Total current liabilities | $87.01M | $83.36M | $92.14M | $87.81M | $87.63M | $88.13M |
| Long-term debt | $124.75M | $129.41M | $130.50M | $131.55M | $132.70M | $132.08M |
| Total liabilities | $281.70M | $286.36M | $317.10M | $320.63M | $334.93M | $343.44M |
| Retained earnings | -$1.38B | -$1.35B | -$1.36B | -$1.33B | -$1.27B | -$1.24B |
| Total equity | $216.34M | $204.44M | $179.72M | $190.42M | $223.77M | $241.60M |